At the center of this controversy lies the UK’s Yellow Card System, a mechanism to report adverse reactions. Though originally paper-based (hence the name “yellow card”), this system has since gone digital. Nonetheless, its efficacy is now under scrutiny.
According to Carl Heneghan, Professor of Evidence-Based Medicine at the University of Oxford, as little as only 2% of adverse reactions are being reported through this system, rendering it basically useless.
2% of vaccine reactions reported:
Therefore up to 98% not reported. A system beset by conflicts of interest
MHRA approach to patient safety requires a radical overhaul encompassing legislative changes on reporting and,
in a system beset by conflicts of interest, changes to how the MHRA is funded.
A failure to act will only lead to more harm. (Dr John Cambbell/YT)